Empiric Antibiotic for Septic Arthritis
For adult patients with septic arthritis and no identified pathogen, empiric therapy should cover Staphylococcus aureus (primarily methicillin-sensitive) and streptococci, with vancomycin added only when specific MRSA risk factors are present.
Recommended Empiric Regimen
Standard Coverage (No MRSA Risk Factors)
Use a beta-lactam antibiotic as first-line therapy:
- Nafcillin or oxacillin 1-2 g IV every 4 hours 1
- Cefazolin 1 g IV every 8 hours (alternative for non-severe penicillin allergy) 1
- Amoxicillin-clavulanate provides adequate coverage in 84-89% of large joint infections 2, 3
This approach is supported by recent epidemiologic data showing methicillin-sensitive S. aureus (MSSA) remains the predominant pathogen (44-52% of cases), with streptococci accounting for another 14-15% 4, 2, 3. MRSA is rare in community-acquired septic arthritis, representing only 4-5% of cases 4, 2, 3.
When to Add MRSA Coverage
Add vancomycin 15-20 mg/kg IV every 8-12 hours (target trough 15-20 mg/mL) when ANY of these risk factors are present: 1
- Known MRSA colonization (strongest individual risk factor)
- Prior MRSA infection
- Recent healthcare exposure or hospitalization
- IV antibiotic use within 90 days
- High local MRSA prevalence (>20% of S. aureus isolates)
- Septic shock or severe systemic toxicity
Alternative to vancomycin: Linezolid 600 mg IV/PO every 12 hours 1
Special Considerations
Small Joint Infections
For hand/wrist infections, particularly in diabetic patients, consider broader coverage with piperacillin-tazobactam 4.5 g IV every 6 hours as these infections have higher rates of gram-negative organisms (including Pseudomonas) 3. However, this is NOT necessary for large joint infections where gram-negatives remain uncommon (10-15% overall) 4, 2.
Gram-Negative Coverage
Routine antipseudomonal coverage is NOT warranted for native joint septic arthritis 2, 3. Add coverage only if:
- Small joint infection in diabetic patient
- Chronic wounds with prior antibiotic exposure
- Previous Pseudomonas isolation
- Recent surgical procedure (within 3 months)
Penicillin Allergy
Avoid clindamycin - recent data shows significant resistance (up to 40% in some periods) 4. Instead use:
- Vancomycin if severe/immediate hypersensitivity reaction
- Cefazolin if non-severe allergy (cross-reactivity <1%)
Critical Pitfalls to Avoid
Do NOT routinely cover MRSA - this represents antibiotic overuse in 95% of community-acquired cases 4, 2
Do NOT use clindamycin empirically - resistance patterns make this unreliable despite historical use 4
Do NOT delay drainage for antibiotics - surgical drainage/arthroscopic washout is the mainstay of therapy and should be performed urgently 1, 5
Do NOT use antipseudomonal agents for large joints - Pseudomonas is exceedingly rare in knee/hip/shoulder septic arthritis without specific risk factors 2, 3
Tailoring Therapy
Once culture results return (positive in approximately 50% of cases), narrow antibiotics to the most specific agent 2. For proven MSSA, transition to:
- Nafcillin, oxacillin, or cefazolin (preferred definitive agents) 1
Duration of therapy is typically 3-4 weeks IV, though this should be guided by clinical response and inflammatory marker normalization (CRP, ESR) 6, 7.
The age-related pathogen distribution shows S. aureus predominates in younger adults (18-64 years), while Streptococcus species are more common in patients >65 years, though this doesn't change empiric coverage recommendations 4.